COMBACTE Abstract Overview ECCMID 2019
Did you miss the COMBACTE abstracts during ECCMID 2019? You can still check them out on the ECCMID website:
- One Health platform to retrieve up-to-date surveillance data on antimicrobial resistance from humans and animals in Europe. Session: Using new tools to identify and measure healthcare-associated infections
- Comparison of PCRribotypes and toxinotypes causing community v ersus hospital Clostridium difficile infection. Oral session: Controlling C. difficile in and out of the hospital
- Detection of Clostridium difficile infection across whole healthcare economies in Europe: results from COMBACTE-CDI. Paper poster session: CDI epidemiology and control
- Investigation of Clostridium difficile positive and negative samples using an ultra-sensitive toxin detection assay and BIOFIRE FILMARRAY Gastrointestinal Panel. Paper poster session: More to learn about CDI; molecular diagnostics and epidemiology
- Competing event analysis of the impact of antibiotic exposure on the development of multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia. Session: Risks and outcomes of MDR Gram-negative infection
- Phase II, open-label REJUVENATE study of the pharmacokinetics and safety of aztreonam-avibactam plus metronidazole in hospitalised adults with complicated intra-abdominal infections. Session: Safety of antibacterial agents in the clinic
- Population pharmacokinetics of imipenem in critically ill patients: a comparison between parametric and nonparametric methods. Session: Current issues in clinical pharmacokinetics
- Reporting surveillance data on antibiotic resistance to inform stewardship teams: a call for guidance document. Session: Two sides of a coin: diagnostic and antimicrobial stewardship
- Efficacy and Safety Profile of Suvratoxumab, a Novel Anti-Staphylococcus aureus Monoclonal Antibody: Results of the SAATELLITE Study in Mechanically Ventilated Intensive Care Unit Patients. Session: Recent clinical trials
- Occurrence of Staphylococcus aureus ICU pneumonia in Europe: preliminary results from a COMBACTE consortium study. Session: Surveillance of healthcare-associated infections